世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

安定同位体標識化合物市場:タイプ毎、用途毎(研究、臨床診断、工業)エンドユーザ毎(医薬・バイオ医薬企業、学術・研究機関)、地域毎 - 2024年までの世界市場予測

Stable Isotope Labeled Compounds Market by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute), Region - Global Forecast to 2024

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2020年1月US$5,650
シングルユーザライセンス
146 139

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の安定同位体標識化合物市場に関する調査レポートです。

“The stable isotope labeled compounds market is projected to grow at a CAGR of 3.0% during the forecast period (2019-2024).”

The global stable isotope labeled compounds market size is projected to reach USD 312 million by 2024 from USD 269 million in 2019, at a CAGR of 3.0%. The growth of this market is driven majorly by factors such as the increase in research activities in the pharmaceutical and biotechnology sector, rising proteomics research, and the rising prevalence of cancer. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period.

“By type, the H-2 labeled compounds segment is expected to grow at the highest CAGR during the forecast period.”

Based on component, the stable isotope-labeled compounds market is segmented into C-13, N-15, O-18, H-2 (deuterium), and other isotopes. The H-2 labeled compounds segment accounted for the largest market share in 2018. This segment is also expected to register the highest growth during the forecast period. This growth in this segment is driven primarily by growing drug research in the pharmaceutical industry and the increasing availability of deuterium-labeled compounds.

“By application, the research segment dominated the stable isotope labeled compounds market in 2018.”

Based on technology, the stable isotope-labeled compounds market is segmented into research, clinical diagnostics, industrial applications, and other applications. The research segment accounted for the largest share of the stable isotope-labeled compounds market in 2018, owing to rising research activities in the biomedical, pharmaceutical, environmental & ecological, and agricultural sectors.

“North America stable isotope labeled compounds market is expected to witness the highest growth during the forecast period.”

The North America region market is estimated to grow at the highest CAGR during the forecast period, primarily due to the growing pharmaceutical and biopharmaceutical industry, support from the Isotope Production and Distribution Program Fund, and the presence of a large nuclear industry are driving market growth in the region.

A breakdown of the primary participants referred to for this report is provided below:

- By Company Type: Tier 1-21%, Tier 2-26%, and Tier 3-53%
- By Designation: C-level-32%, Director-level-26%, and Others-42%
- By Region: North America-34%, Europe-29%, Asia Pacific-27%, RoW-10%

The prominent players operating in the global stable isotope labeled compounds market include PerkinElmer Inc. (US), Merck KGaA (Germany), Cambridge Isotope Laboratories, Inc. (US), URENCO Limited (UK), IsoSciences, LLC (US), Medical Isotopes, Inc. (US), Omicron Biochemicals, Inc. (US), Trace Sciences International (US), Alsachim (France), Taiyo Nippon Sanso Corporation (Japan), and Rotem Industries Israel Ltd. (Israel).

Research Coverage:

The report analyzes the stable isotope labeled compounds market and aims at estimating the market size and future growth potential. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the stable isotope labeled compounds market
- Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the stable isotope labeled compounds market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new systems, growing geographies, and recent developments in the global stable isotope labeled compounds market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and services of the leading players in the stable isotope labeled compounds market



目次

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.2.1 MARKET SCOPE 17
1.2.2 MARKETS COVERED 17
1.2.3 YEARS CONSIDERED FOR THE STUDY 18
1.3 CURRENCY 18
1.4 LIMITATIONS 18
1.5 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.2 SECONDARY DATA 21
2.2.1 KEY DATA FROM SECONDARY SOURCES 22
2.3 PRIMARY DATA 23
2.3.1 KEY DATA FROM PRIMARY SOURCES 23
2.4 MARKET SIZE ESTIMATION 24
2.4.1 REVENUE MAPPING-BASED MARKET ESTIMATION 25
2.5 DATA TRIANGULATION 27
2.5.1 ASSUMPTIONS FOR THE STUDY 28
2.5.2 LIMITATIONS 28

3 EXECUTIVE SUMMARY 29

4 PREMIUM INSIGHTS 32
4.1 STABLE ISOTOPE-LABELED COMPOUNDS MARKET OVERVIEW 32
4.2 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION (2018) 33
4.3 GEOGRAPHICAL SNAPSHOT OF THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET 34

5 MARKET OVERVIEW 35
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 DRIVERS 36
5.2.1.1 Increase in research activities in the pharmaceutical & biotechnology sectors 36
5.2.1.2 Growing proteomics research 37
5.2.1.3 Growing prevalence of cancer 37
5.2.2 RESTRAINTS 38
5.2.2.1 High cost of stable isotope-labeled compounds 38
5.2.3 OPPORTUNITIES 38
5.2.3.1 Growing investments in pharmaceutical R&D in emerging markets 38
5.2.4 CHALLENGES 39
5.2.4.1 Dearth of skilled professionals 39

6 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE 40
6.1 INTRODUCTION 41
6.2 HYDROGEN-2 41
6.2.1 GROWING APPLICATIONS OF H-2 IN PHARMACEUTICAL RESEARCH WILL DRIVE THE DEMAND FOR LABELED COMPOUNDS 41
6.3 CARBON-13 43
6.3.1 GROWING NUMBER OF METABOLOMICS STUDIES AND APPLICATIONS IN DISEASE DIAGNOSIS ARE DRIVING MARKET GROWTH 43
6.4 OXYGEN-18 45
6.4.1 INCREASING RESEARCH ON CANCER IS EXPECTED TO DRIVE THE DEMAND FOR OXYGEN-18-LABELED ISOTOPES 45
6.5 NITROGEN-15 47
6.5.1 EXPANDING APPLICATIONS OF N-15 IN AGRICULTURAL INVESTIGATION AND RISING RESEARCH ARE LIKELY TO DRIVE MARKET DEMAND 47
6.6 OTHER STABLE ISOTOPES 49

7 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION 51
7.1 INTRODUCTION 52
7.2 RESEARCH APPLICATIONS 52
7.2.1 BIOMEDICAL RESEARCH 52
7.2.1.1 Increasing number of biomedical research activities involving stable isotopes to drive the stable isotope-labeled compounds market for biomedical research 52
7.2.2 PHARMACEUTICAL RESEARCH 53
7.2.2.1 Stable isotopically modified pharmaceutical agents offer reduced side-effects, improved oral bioavailability, and increased half-life—key factors driving market growth 53
7.2.3 ENVIRONMENTAL & ECOLOGICAL RESEARCH 53
7.2.3.1 Increasing use of stable to study the feeding ecology of living or extinct animal species through the analysis of their ratios in carcasses or remains to drive market growth 53
7.2.4 AGRICULTURAL RESEARCH 54
7.2.4.1 Increasing use of stable isotopes to prevent soil pollution and contamination and facilitate maximum crop production to drive growth in this market 54
7.3 CLINICAL DIAGNOSTICS 56
7.3.1 INCREASING ADOPTION OF PET SCANS AND GAMMA IMAGING FOR DISEASE STAGING TO SUPPORT MARKET GROWTH 56
7.4 INDUSTRIAL APPLICATIONS 58
7.4.1 GROWING APPLICATION OF STABLE ISOTOPES IN THE NUCLEAR INDUSTRY AND THE INCREASING NUMBER OF NUCLEAR REACTORS TO SUPPORT MARKET GROWTH 58
7.5 OTHER APPLICATIONS 60

8 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER 63
8.1 INTRODUCTION 64
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 64
8.2.1 INCREASE IN R&D ACTIVITIES TO DRIVE THE DEMAND FOR STABLE ISOTOPE-LABELED COMPOUNDS AMONG PHARMA & BIOTECH COMPANIES 64
8.3 ACADEMIC & RESEARCH INSTITUTES 67
8.3.1 GROWING RESEARCH ON VARIOUS TREATMENT THERAPIES IS DRIVING THE GROWTH OF THIS END-USER SEGMENT 67
8.4 HOSPITALS & DIAGNOSTIC CENTERS 69
8.4.1 ADOPTION OF STABLE ISOTOPES HAS INCREASED OWING TO THE RISING PREVALENCE OF TARGET DISEASES 69
8.5 OTHER END USERS 71

9 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY REGION 73
9.1 INTRODUCTION 74
9.2 NORTH AMERICA 75
9.2.1 US 77
9.2.1.1 The US dominates the North American stable isotope-labeled compounds market 77
9.2.2 CANADA 79
9.2.2.1 Availability of funding will drive the market in Canada 79
9.3 EUROPE 81
9.3.1 GERMANY 83
9.3.1.1 Germany is the fastest-growing market in Europe 83
9.3.2 UK 85
9.3.2.1 Favorable scenario for environmental research and increasing prevalence of cancer are key growth drivers in the UK 85
9.3.3 FRANCE 87
9.3.3.1 France has a large and well-developed biotech industry 87
9.3.4 ITALY 89
9.3.4.1 Strong government support for research has stimulated market growth in Italy 89
9.3.5 SPAIN 90
9.3.5.1 Increasing research activities and expenditure shows significant market growth potential in Spain 90
9.3.6 REST OF EUROPE 92
9.4 ASIA PACIFIC 94
9.4.1 CHINA 97
9.4.1.1 China dominates the stable isotope-labeled compounds market in the APAC 97
9.4.2 JAPAN 99
9.4.2.1 Growing support and funding have raised research intensity in Japan 99
9.4.3 INDIA 101
9.4.3.1 Government initiatives have strengthened the life science industry in India 101
9.4.4 AUSTRALIA 103
9.4.4.1 Growing funding for research and collaborations have supported market growth in Australia 103
9.4.5 REST OF ASIA PACIFIC 105
9.5 REST OF THE WORLD 107

10 COMPETITIVE LANDSCAPE 110
10.1 OVERVIEW 110
10.2 MARKET SHARE ANALYSIS, 2018 110
10.3 COMPETITIVE SCENARIO 111
10.4 COMPETITIVE LEADERSHIP MAPPING (2018) 112
10.4.1 VISIONARY LEADERS 112
10.4.2 INNOVATORS 112
10.4.3 DYNAMIC DIFFERENTIATORS 112
10.4.4 EMERGING COMPANIES 112

11 COMPANY PROFILES 114
(Business Overview, Products Offered, Recent Developments, Competitive Analysis, MnM View)*
11.1 CAMBRIDGE ISOTOPE LABORATORIES 114
11.2 MERCK KGAA 117
11.3 URENCO LIMITED 119
11.4 ISOSCIENCES 121
11.5 MEDICAL ISOTOPES 123
11.6 OMICRON BIOCHEMICALS 124
11.7 TRACE SCIENCES INTERNATIONAL 125
11.8 ALSACHIM 127
11.9 TAIYO NIPPON SANSO CORPORATION 128
11.10 PERKINELMER 129
11.11 ROTEM INDUSTRIES ISRAEL 131
11.12 BOC SCIENCES 132
11.13 CORTECNET 133
11.14 ISOFLEX 134
11.15 HUAYI ISOTOPES CO. 135
11.16 MESBAH ENERGY CO. 135
11.17 SHANGHAI RESEARCH INSTITUTE OF CHEMICAL INDUSTRY 135
11.18 13C MOLECULAR 136
11.19 C/D/N ISOTOPES 137
11.20 SHOKO CO. 137
*Business Overview, Products Offered, Recent Developments, Competitive Analysis, MnM View might not be captured in case of unlisted companies.

12 APPENDIX 138
12.1 DISCUSSION GUIDE 138
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 142
12.3 AVAILABLE CUSTOMIZATIONS 144
12.4 RELATED REPORTS 144
12.5 AUTHOR DETAILS 145

 

LIST OF TABLES

TABLE 1 COMPANY DRUG PIPELINES, 2019 36
TABLE 2 TOP INVESTORS IN R&D, 2016 VS. 2017 36
TABLE 3 GLOBAL CANCER INCIDENCE, 2018 VS. 2025 37
TABLE 4 GOVERNMENT FUNDING PROGRAMS FOR PHARMACEUTICAL R&D IN EMERGING NATIONS 38
TABLE 5 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION) 41
TABLE 6 HYDROGEN-2-LABELED COMPOUNDS MARKET, BY REGION, 2017–2022 (USD MILLION) 42
TABLE 7 NORTH AMERICA: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 42
TABLE 8 EUROPE: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 42
TABLE 9 APAC: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND) 43
TABLE 10 CARBON-13-LABELED COMPOUNDS MARKET, BY REGION, 2017–2024 (USD MILLION) 44
TABLE 11 NORTH AMERICA: CARBON-13-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 44
TABLE 12 EUROPE: CARBON-13-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 44
TABLE 13 APAC: C CARBON-13-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND) 45
TABLE 14 OXYGEN-18-LABELED COMPOUNDS MARKET, BY REGION, 2017–2024 (USD MILLION) 45
TABLE 15 NORTH AMERICA: OXYGEN-18-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 46
TABLE 16 EUROPE: OXYGEN-18-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 46
TABLE 17 APAC: OXYGEN-18-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND) 47
TABLE 18 NITROGEN-15-LABELED COMPOUNDS MARKET, BY REGION, 2017–2022 (USD MILLION) 47
TABLE 19 NORTH AMERICA: NITROGEN-15-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 48
TABLE 20 EUROPE: NITROGEN-15-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 48
TABLE 21 APAC: NITROGEN-15-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND) 49
TABLE 22 OTHER STABLE ISOTOPES MARKET, BY REGION, 2017–2022 (USD THOUSAND) 49
TABLE 23 NORTH AMERICA: OTHER STABLE ISOTOPES MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND) 50
TABLE 24 EUROPE: OTHER STABLE ISOTOPES MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND) 50
TABLE 25 APAC: OTHER STABLE ISOTOPES MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND) 50
TABLE 26 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 52
TABLE 27 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2017–2024 (USD MILLION) 54
TABLE 28 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 54
TABLE 29 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 55
TABLE 30 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 55
TABLE 31 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2017–2024 (USD MILLION) 56
TABLE 32 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017–2024 (USD MILLION) 57
TABLE 33 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017–2024 (USD MILLION) 57
TABLE 34 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017–2024 (USD THOUSAND) 58
TABLE 35 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2017–2024 (USD MILLION) 58
TABLE 36 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 59
TABLE 37 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND) 59
TABLE 38 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND) 60
TABLE 39 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION) 61
TABLE 40 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND) 61
TABLE 41 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND) 62
TABLE 42 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND) 62
TABLE 43 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION) 64
TABLE 44 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION) 65
TABLE 45 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION) 65
TABLE 46 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION) 66
TABLE 47 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD THOUSAND) 66
TABLE 48 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017–2024 (USD MILLION) 67
TABLE 49 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION) 67
TABLE 50 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION) 68
TABLE 51 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD THOUSAND) 68
TABLE 52 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2015–2022 (USD MILLION) 69
TABLE 53 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2017–2024 (USD THOUSAND) 69
TABLE 54 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2017–2024 (USD THOUSAND) 70
TABLE 55 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2017–2024 (USD THOUSAND) 70
TABLE 56 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY REGION, 2015–2022 (USD MILLION) 71
TABLE 57 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD THOUSAND) 71
TABLE 58 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD THOUSAND) 72
TABLE 59 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD THOUSAND) 72
TABLE 60 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY REGION, 2017–2024 (USD MILLION) 74
TABLE 61 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 76
TABLE 62 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION) 76
TABLE 63 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 76
TABLE 64 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION) 77
TABLE 65 US: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION) 78
TABLE 66 US: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 78
TABLE 67 US: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION) 79
TABLE 68 CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 80
TABLE 69 CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND) 80
TABLE 70 CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND) 81
TABLE 71 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 81
TABLE 72 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION) 82
TABLE 73 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 82
TABLE 74 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION) 83
TABLE 75 GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION) 84
TABLE 76 GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 84
TABLE 77 GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION) 85
TABLE 78 UK: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION) 86
TABLE 79 UK: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 86
TABLE 80 UK: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION) 87
TABLE 81 FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 88
TABLE 82 FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND) 88
TABLE 83 FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD THOUSAND) 89
TABLE 84 ITALY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 89
TABLE 85 ITALY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND) 90
TABLE 86 ITALY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND) 90
TABLE 87 SPAIN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 91
TABLE 88 SPAIN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND) 91
TABLE 89 SPAIN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND) 92
TABLE 90 PHARMACEUTICAL R&D EXPENDITURE IN ROE COUNTRIES (2016) 92
TABLE 91 ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 93
TABLE 92 ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND) 93
TABLE 93 ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND) 94
TABLE 94 NUMBER OF NUCLEAR REACTORS IN THE ASIA PACIFIC (AUGUST 2019) 94
TABLE 95 ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 96
TABLE 96 ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION) 96
TABLE 97 ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 96
TABLE 98 ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION) 97
TABLE 99 CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION) 98
TABLE 100 CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 98
TABLE 101 CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION) 99
TABLE 102 JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 100
TABLE 103 JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD THOUSAND) 100
TABLE 104 JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND) 101
TABLE 105 INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 102
TABLE 106 INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND) 102
TABLE 107 INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND) 103
TABLE 108 AUSTRALIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 104
TABLE 109 AUSTRALIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND) 104
TABLE 110 AUSTRALIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND) 105
TABLE 111 ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 106
TABLE 112 ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND) 106
TABLE 113 ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND) 107
TABLE 114 ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 108
TABLE 115 ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND) 108
TABLE 116 ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND) 109
TABLE 117 AGREEMENTS (2016–2019) 111
TABLE 118 PRODUCT LAUNCHES (2016-2019) 111

 

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 20
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 24
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 25
FIGURE 4 MARKET SIZE ESTIMATION: STABLE ISOTOPE-LABELED COMPOUNDS MARKET 26
FIGURE 5 MARKET DATA TRIANGULATION METHODOLOGY 27
FIGURE 6 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION) 29
FIGURE 7 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION) 30
FIGURE 8 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION) 30
FIGURE 9 GEOGRAPHIC SNAPSHOT OF THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET 31
FIGURE 10 INCREASE IN RESEARCH IN THE PHARMACEUTICAL & BIOTECHNOLOGY SECTORS WILL DRIVE MARKET GROWTH 32
FIGURE 11 RESEARCH APPLICATIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2018 33
FIGURE 12 NORTH AMERICA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 34
FIGURE 13 STABLE ISOTOPE-LABELED COMPOUNDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 35
FIGURE 14 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET SNAPSHOT 75
FIGURE 15 ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET SNAPSHOT 95
FIGURE 16 MARKET RANKING OF KEY PLAYERS, 2018 110
FIGURE 17 COMPETITIVE LEADERSHIP MAPPING: STABLE ISOTOPE-LABELED COMPOUNDS MARKET 113
FIGURE 18 MERCK KGAA: COMPANY SNAPSHOT 117
FIGURE 19 URENCO LIMITED: COMPANY SNAPSHOT (2018) 119
FIGURE 20 TAIYO NIPPON SANSO CORPORATION: COMPANY SNAPSHOT (2018) 128
FIGURE 21 PERKINELMER: COMPANY SNAPSHOT (2018) 129

 

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る